Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBY3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,621
Award facts
- Contract value 100% obligated
- $43,621.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 200-unit vials of BOTOX. This firm fixed-price delivery order, valued at $43,621.20, was awarded on January 22, 2026, with an ultimate completion date of February 12, 2026. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. Performance will take place in Park Ridge, Illinois, with DMS Pharmaceutical Group serving as the sole contractor on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, was awarded on November 13, 2025, and authorizes DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. This delivery order exemplifies DMS Pharmaceutical Group's role as a critical regional pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBY3?
SPE2DR26FFBY3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FFBY3 worth?
The government has obligated $43,621 on SPE2DR26FFBY3.
Is contract SPE2DR26FFBY3 an order under another contract?
Yes. SPE2DR26FFBY3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBY3 competed?
The extent of competition for SPE2DR26FFBY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award